albendazole has been researched along with Cyst in 49 studies
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with albendazole was associated with a reduction in the number of seizures during 24 months of follow-up, but this was only significant for generalized seizures during months 1-12 (unadjusted rate ratio [RR] 0." | 9.20 | The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leslie, D; Romo, ML; Wyka, K, 2015) |
"Albendazole plus symptomatic treatment leads to the disappearance of active cysts in 31% of patients compared with 7% of those with symptomatic treatment alone." | 9.13 | Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leon, P; Leslie, D, 2008) |
"A retrospective case series, 2005-2021, assessing factors leading to albendazole monotherapy, demographic, clinical, duration of treatment and follow-up, and outcome (changes in cyst size and side effects) characteristics." | 8.31 | Albendazole Monotherapy for Pediatric Cystic Echinococcosis: A Case Series. ( Assi, Z; Ben-Shimol, S; Elamour, S; Grupel, D; Sagi, O; Shmueli, M, 2023) |
"The tolerability and efficiency of specific chemotherapy with albendazole were analyzed in 18 patients with cystic echinococcosis at various sites." | 7.85 | [(EXPERIENCE WITH ALBENDAZOLE TREATMENT IN CHILDREN WITH CYSTIC ECHINOCOCCOSIS)]. ( Bronshtein, AM; Legonkov, YA, 2017) |
" granulosus cysts were marked in liposomal albendazole combined with cimetidin group." | 7.70 | [Effect of liposomal albendazole on the ultrastructure of Echinococcus granulosus cysts in mice]. ( Liu, W; Shao, Y; Wen, H, 1999) |
"Albendazole sulfoxide injection as a scolecidal agent in the percutaneous treatment of cystic echinococcosis seems to be effective in this animal model." | 7.70 | A new therapeutic approach for the treatment of cystic echinococcosis: percutaneous albendazole sulphoxide injection without reaspiration. ( Asil, M; Deger, BA; Deger, E; Hokelek, M; Pakdemirli, E; Tutar, E, 2000) |
"Pharmacokinetic data of 121 individual cysts were analysed." | 6.53 | Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data. ( Auer, H; Groger, M; Kaczirek, K; Lötsch, F; Naderer, J; Ramharter, M; Skuhala, T; Waneck, F, 2016) |
"Cystic echinococcosis is a worldwide zoonotic disease caused by Echinococcus granulosus sensu lato (s." | 5.91 | Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole. ( Albanese, A; Albani, C; Elissondo, MC; Fabbri, J; Paladini, A; Pensel, P, 2023) |
"Primary Renal hydatid cyst is a rare entity." | 5.91 | Renal Hydatid Cyst in a Child Managed with Albendazole. ( Acharya, S; Kc, SR; Pandey, U; Paudel, U; Pradhan, S; Timilsina, BR, 2023) |
" Conclusion: Praziquantel is effective and safe in the treatment of patients with neurocysticercosis." | 5.72 | Efficacy and safety of praziquantel in the treatment of neurocysticercosis in Vietnam. ( Loi, CB; Phuc, TQ; Thang, TD; Thanh, DT; Thieu, NQ; Tho, TH; Tran-Anh, L, 2022) |
"Protoscoleces and microcysts were treated in vitro with free ABZ and ABZ-NLCs (concentrations of 1, 5, and 10 μg/ml), and the corresponding effects were monitored by methylene blue exclusion test and scanning and transmission electron microscopy." | 5.62 | In vitro evaluation of albendazole-loaded nanostructured lipid carriers on Echinococcus granulosus microcysts and their prophylactic efficacy on experimental secondary hydatidosis. ( Ahmadi, N; Farhadi, M; Haniloo, A; Rostamizadeh, K, 2021) |
"Echinococcus granulosus causes hydatidosis or cystic echinococcosis in humans and livestock." | 5.48 | Could beta-myrcene be an alternative to albendazole for the treatment of experimental cystic echinococcosis? ( Albani, CM; Denegri, GM; Elissondo, MC; Fabbri, J; Maggiore, MA; Pensel, PE, 2018) |
"The onset of anthelmintic treatment of neurocysticercosis (NCC) provokes an acute immune response of the host, which in human cases is associated with exacerbation of neurological symptoms." | 5.46 | Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole. ( Arroyo, G; Bustos, JA; Calcina, J; Cangalaya, C; Chacaltana, J; García, HH; Gonzalez, AE; Guerra-Giraldez, C; Mahanty, S; Mamani, J; Nash, TE; Suarez, D; Vargas-Calla, A, 2017) |
"Treatment with albendazole was associated with a reduction in the number of seizures during 24 months of follow-up, but this was only significant for generalized seizures during months 1-12 (unadjusted rate ratio [RR] 0." | 5.20 | The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leslie, D; Romo, ML; Wyka, K, 2015) |
"Albendazole plus symptomatic treatment leads to the disappearance of active cysts in 31% of patients compared with 7% of those with symptomatic treatment alone." | 5.13 | Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leon, P; Leslie, D, 2008) |
"Seeking better immunological markers indicating the long-term outcome of cystic echinococcosis (CE) after chemotherapy we studied 23 patients receiving albendazole, clinically followed for 8 years, and grouped ultrasonographically according to therapeutic outcome." | 5.10 | Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates. ( Ali, MD; Di Vico, B; Ioppolo, S; Margutti, P; Ortona, E; Profumo, E; Riganò, R; Siracusano, A; Teggi, A, 2002) |
"Following neoadjuvant albendazole for 4 weeks to minimize any effects in case of inadvertent cyst spillage, the patient tested negative for echinococcal antibody." | 4.31 | Central Pericystectomy for Hydatid Cyst Treatment. ( Conrad, C; Salehi, O; Vega, EA, 2023) |
"Cyst resolution was unsatisfactory with albendazole monotherapy but was very high when it was followed by a combination of albendazole and praziquantel." | 4.31 | Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study. ( Bottieau, E; Carabin, H; Dorny, P; Fleury, A; Gabriël, S; Jackson, E; Magnussen, P; Makasi, C; Mwape, KE; Ngowi, BJ; Prazeres da Costa, C; Prodjinotho, UF; Ruether, C; Schmidt, V; Stelzle, D; Trevisan, C; Van Damme, I; Winkler, AS; Zulu, G, 2023) |
"A retrospective case series, 2005-2021, assessing factors leading to albendazole monotherapy, demographic, clinical, duration of treatment and follow-up, and outcome (changes in cyst size and side effects) characteristics." | 4.31 | Albendazole Monotherapy for Pediatric Cystic Echinococcosis: A Case Series. ( Assi, Z; Ben-Shimol, S; Elamour, S; Grupel, D; Sagi, O; Shmueli, M, 2023) |
"Available treatments for uncomplicated hepatic cystic echinococcosis (CE) include surgery, medical therapy with albendazole (ABZ), percutaneous interventions and the watch-and-wait (WW) approach." | 3.80 | Medical treatment versus "Watch and Wait" in the clinical management of CE3b echinococcal cysts of the liver. ( Brunetti, E; Cattaneo, F; De Silvestri, A; Lissandrin, R; Rinaldi, F; Tamarozzi, F, 2014) |
" granulosus cysts were marked in liposomal albendazole combined with cimetidin group." | 3.70 | [Effect of liposomal albendazole on the ultrastructure of Echinococcus granulosus cysts in mice]. ( Liu, W; Shao, Y; Wen, H, 1999) |
"Albendazole sulfoxide injection as a scolecidal agent in the percutaneous treatment of cystic echinococcosis seems to be effective in this animal model." | 3.70 | A new therapeutic approach for the treatment of cystic echinococcosis: percutaneous albendazole sulphoxide injection without reaspiration. ( Asil, M; Deger, BA; Deger, E; Hokelek, M; Pakdemirli, E; Tutar, E, 2000) |
"While uncomplicated cysts usually appear at imaging as well-defined homogeneous lesions with fluid content and smooth walls of variable thickness, complicated lesions may have a more heterogeneous content with higher density making more difficult the distinction from malignancies or other infections." | 3.01 | An unexpected guest: Pulmonary echinococcosis diagnosed by intraoperative frozen section examination. A case report and literature review. ( Bonis, A; Calabrese, F; Giraudo, C; Lunardi, F; Maggioni, G; Pezzuto, F; Schiavon, M, 2023) |
"Most cysts are in the liver." | 3.01 | Pulmonary cystic echinococcosis. ( Junghanss, T; Stojković, M; Weber, TF, 2023) |
"Treatment with albendazole, whether combined or not with praziquantel, is useful for smaller, uncomplicated cysts (< 5 cm)." | 2.82 | A review of the diagnosis and management of liver hydatid cyst. ( Ferrer Inaebnit, E; González Argenté, X; Molina Romero, FX; Morón Canis, JM; Segura Sampedro, JJ, 2022) |
"In patients with hepatic cystic echinococcosis (CE), treatment effectiveness, outcomes, complications, and recurrence rate are controversial." | 2.72 | Endocystectomy as a conservative surgical treatment for hepatic cystic echinococcosis: A systematic review with single-arm meta-analysis. ( Al-Saeedi, M; Ali-Hasan-Al-Saegh, S; El Rafidi, A; Ghamarnejad, O; Hoffmann, K; Khajeh, E; Mehrabi, A; Probst, P; Ramouz, A; Shafiei, S; Stojkovic, M; Weber, TF, 2021) |
"The abdominal cysts were categorised as small (<5 cm in diameter) or large." | 2.71 | The types and timing of the degenerative changes seen in the cysts during and after benzimidazole treatment of cystic echinococcosis. ( Donev, S; Ivanov, A; Katzarov, K; Takov, D; Todorov, T; Vutova, K, 2005) |
"Cysts were treated with a one-stage procedure that consisted of puncture of the cysts under guidance with computed tomography, aspiration of fluid, injection of hypertonic saline solution as scolicidal agent and reaspiration." | 2.69 | PAIR as percutaneous treatment of hydatid liver cysts. ( Correa, D; Del Carpio, M; Guangiroli, M; Kugler, C; Lopez, E; Marcos, B; Molina, J; Peláez, V, 2000) |
"Diagnosis and therapy in hepatic hydatid cysts have been significantly advanced by imaging, interventional radiology and surgical approaches in recent years." | 2.58 | Hepatic cystic echinococcosis in Australia: an update on diagnosis and management. ( Fox, A; Keong, B; Sutherland, T; Wilkie, B, 2018) |
"Pharmacokinetic data of 121 individual cysts were analysed." | 2.53 | Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data. ( Auer, H; Groger, M; Kaczirek, K; Lötsch, F; Naderer, J; Ramharter, M; Skuhala, T; Waneck, F, 2016) |
"We included 49 patients, and 79 cysts that were all surgically treated." | 1.91 | The high burden of pediatric cystic echinococcosis in Kazakhstan: epidemiological and clinical consequences. ( Brunetti, E; Colpani, A; De Vito, A; Doszhanova, G; Duisenova, A; Juszkiewicz, K; Kaniyev, S; Katarbayev, A; Manciulli, T; Mustapayeva, A; Zhakenova, Z; Zholdybay, Z, 2023) |
"Primary Renal hydatid cyst is a rare entity." | 1.91 | Renal Hydatid Cyst in a Child Managed with Albendazole. ( Acharya, S; Kc, SR; Pandey, U; Paudel, U; Pradhan, S; Timilsina, BR, 2023) |
"Treatment with albendazole was administered to 94% of CE, while albendazole monotherapy was used in 27% (n = 18, including 4 cases with extra-hepatic cysts)." | 1.91 | Treatment of Cystic Echinococcosis in Children: A Single Center Experience. ( Assi, Z; Ben-Shimol, S; Fuxman, Y; Gazer, B; Sheves, A; Shmueli, M; Van Buren, J, 2023) |
"Cysticercosis is a parasitic tissue infection caused by larval cysts of Taenia solium." | 1.72 | [A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye]. ( Akbulut, A; Akgün, B; Balgetir, F; Çalık, M; Enez, M; Özer Balin, Ş; Yıldırım, H, 2022) |
"The volume and weight of the cysts were significantly lower in the sumac group compared to the controls." | 1.72 | Anti-echinococcal effects of sumac, Rhus coriaria, in a murine model of cystic echinococcosis: Parasitological and molecular evaluation. ( Afgar, A; Fotoohi, S; Harandi, MF; Radfar, MH, 2022) |
" Conclusion: Praziquantel is effective and safe in the treatment of patients with neurocysticercosis." | 1.72 | Efficacy and safety of praziquantel in the treatment of neurocysticercosis in Vietnam. ( Loi, CB; Phuc, TQ; Thang, TD; Thanh, DT; Thieu, NQ; Tho, TH; Tran-Anh, L, 2022) |
"Thirty patients with CE3b cysts and 37 patients with spontaneously-inactivated CE4-CE5 cysts were recruited (T0)." | 1.62 | Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts. ( Brunetti, E; Goletti, D; Gomez Morales, MA; Ludovisi, A; Mariconti, M; Najafi Fard, S; Petrone, L; Tamarozzi, F; Vola, A, 2021) |
"Cystic Echinococcosis or Hydatid disease is caused by the infection with the larval stage of long tapeworm, Echinococcus granulosus." | 1.62 | Rare Encounter of Renal Hydatid Cyst: A Case Report. ( Basnet, P; Chapagain, S; Neupane, R; Thapa, A, 2021) |
"Protoscoleces and microcysts were treated in vitro with free ABZ and ABZ-NLCs (concentrations of 1, 5, and 10 μg/ml), and the corresponding effects were monitored by methylene blue exclusion test and scanning and transmission electron microscopy." | 1.62 | In vitro evaluation of albendazole-loaded nanostructured lipid carriers on Echinococcus granulosus microcysts and their prophylactic efficacy on experimental secondary hydatidosis. ( Ahmadi, N; Farhadi, M; Haniloo, A; Rostamizadeh, K, 2021) |
"The cysts were removed intact." | 1.48 | Hydatid Cyst of Skeletal Muscle Presenting as Soft Tissue Tumour. ( Alam, A; Bhatti, A; Khan, KM; Kumar, M; Minhas, MS; Moghul, FA; Mughal, A; Sangani, MM, 2018) |
"Management options for cystic echinococcosis (CE) remain a serious problem." | 1.48 | Management of cystic echinococcosis in the last two decades: what have we learned? ( Alonso-Sardón, M; Belhassen-García, M; Bellvis, LM; Iglesias Gomez, A; Iglesias-Iglesias, M; Jimenez Lopez, MF; Lopez-Bernus, A; Muñoz Bellido, JL; Muro, A; Pardo-Lledías, J; Romero-Alegria, A; Sampedro, JQ; Velasco-Tirado, V, 2018) |
"Four other cysts (26." | 1.46 | Preliminary Evaluation of Percutaneous Treatment of Echinococcal Cysts without Injection of Scolicidal Agent. ( Brunetti, E; Firpo, G; Lissandrin, R; Tamarozzi, F; Vola, A, 2017) |
"The onset of anthelmintic treatment of neurocysticercosis (NCC) provokes an acute immune response of the host, which in human cases is associated with exacerbation of neurological symptoms." | 1.46 | Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole. ( Arroyo, G; Bustos, JA; Calcina, J; Cangalaya, C; Chacaltana, J; García, HH; Gonzalez, AE; Guerra-Giraldez, C; Mahanty, S; Mamani, J; Nash, TE; Suarez, D; Vargas-Calla, A, 2017) |
"We report a case of a hydatid cyst of the eyelid in a 12-year-old boy associated with cerebral involvement." | 1.43 | Swollen eyelid reveals multiple intracranial hydatid cysts associated with a palpebral cyst. ( Abboud, H; Ahbeddou, S; Ahmimech, J; Berraho, A; Boutarbouch, M; El Hassan, A; Tzili, N, 2016) |
"Hydatid disease is an endemic infection which can affect any organ, mainly the liver and lungs." | 1.40 | Isolated hydatid cyst of uterine cervix: A case report. ( Çaydere, M; Doğan, AÇ; Ergün, Y; Karcaaltincaba, D; Küçük, H; Küçük, Z, 2014) |
"We report a case of renal hydatidosis in a five-year-old child treated in a tertiary pediatric hospital in Argentina." | 1.39 | A five-year-old child with renal hydatidosis. ( Altcheh, J; Freilij, H; García Bournissen, F; Moroni, S; Moscatelli, G; Salgueiro, F, 2013) |
"Giant cysts and racemose forms of neurocysticercosis seem to be more frequent in HIV-infected patients and may be secondary to an uncontrolled parasitic growth because of an impaired cell-mediated immune response." | 1.32 | Unusual form of neurocysticercosis associated with HIV infection. ( Couppie, P; Delobel, P; El Guedj, M; Gueye, M; Pradinaud, R; Signate, A; Smadja, D, 2004) |
"Human cysticercosis is secondary to an infestation by cysticercus cellulosae, the larval form of Taenia solium." | 1.30 | Orbital cysticercosis. ( Lemke, BN; Sekhar, GC, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (4.08) | 18.2507 |
2000's | 10 (20.41) | 29.6817 |
2010's | 17 (34.69) | 24.3611 |
2020's | 20 (40.82) | 2.80 |
Authors | Studies |
---|---|
Basnet, P | 1 |
Chapagain, S | 1 |
Neupane, R | 1 |
Thapa, A | 1 |
Farhadi, M | 1 |
Haniloo, A | 1 |
Rostamizadeh, K | 1 |
Ahmadi, N | 1 |
Tüz, AE | 1 |
Ekemen Keleş, Y | 1 |
Şahin, A | 1 |
Üstündağ, G | 1 |
Taşar, S | 1 |
Karadağ Öncel, E | 1 |
Kara Aksay, A | 1 |
Öztan, MO | 1 |
Köylüoğlu, G | 1 |
Çapar, AE | 1 |
Yılmaz Çiftdoğan, D | 1 |
Thang, TD | 1 |
Phuc, TQ | 1 |
Thanh, DT | 1 |
Thieu, NQ | 1 |
Tho, TH | 1 |
Loi, CB | 1 |
Tran-Anh, L | 1 |
Fotoohi, S | 1 |
Radfar, MH | 1 |
Afgar, A | 1 |
Harandi, MF | 1 |
Albani, C | 3 |
Pensel, P | 3 |
Fabbri, J | 4 |
Albanese, A | 3 |
Paladini, A | 3 |
Elissondo, MC | 4 |
Özer Balin, Ş | 3 |
Enez, M | 3 |
Akbulut, A | 3 |
Çalık, M | 3 |
Akgün, B | 3 |
Balgetir, F | 3 |
Yıldırım, H | 3 |
Mandal, KC | 2 |
Halder, P | 2 |
Mondal, G | 2 |
Debnath, B | 2 |
Mitra, D | 2 |
Mukhopadhyay, B | 2 |
Sheves, A | 1 |
Fuxman, Y | 1 |
Gazer, B | 1 |
Shmueli, M | 2 |
Van Buren, J | 1 |
Ben-Shimol, S | 2 |
Assi, Z | 2 |
Stelzle, D | 1 |
Makasi, C | 1 |
Schmidt, V | 1 |
Trevisan, C | 1 |
Van Damme, I | 1 |
Ruether, C | 1 |
Dorny, P | 1 |
Magnussen, P | 1 |
Zulu, G | 1 |
Mwape, KE | 1 |
Bottieau, E | 1 |
Prazeres da Costa, C | 1 |
Prodjinotho, UF | 1 |
Carabin, H | 1 |
Jackson, E | 1 |
Fleury, A | 1 |
Gabriël, S | 1 |
Ngowi, BJ | 1 |
Winkler, AS | 1 |
Pandey, U | 1 |
Timilsina, BR | 1 |
Acharya, S | 1 |
Paudel, U | 1 |
Kc, SR | 1 |
Pradhan, S | 1 |
Vega, EA | 1 |
Salehi, O | 1 |
Conrad, C | 1 |
Maggioni, G | 1 |
Bonis, A | 1 |
Schiavon, M | 1 |
Giraudo, C | 1 |
Lunardi, F | 1 |
Pezzuto, F | 1 |
Calabrese, F | 1 |
Peulier-Maitre, E | 1 |
Hervieux, E | 1 |
Bigot, J | 1 |
Sileo, C | 1 |
Denamur, S | 1 |
Corvol, H | 1 |
Elamour, S | 1 |
Sagi, O | 1 |
Grupel, D | 1 |
Weber, TF | 2 |
Junghanss, T | 1 |
Stojković, M | 2 |
Doszhanova, G | 1 |
Colpani, A | 1 |
Duisenova, A | 1 |
De Vito, A | 1 |
Zholdybay, Z | 1 |
Juszkiewicz, K | 1 |
Brunetti, E | 4 |
Katarbayev, A | 1 |
Kaniyev, S | 1 |
Zhakenova, Z | 1 |
Manciulli, T | 1 |
Mustapayeva, A | 1 |
Al-Saeedi, M | 1 |
Ramouz, A | 1 |
Khajeh, E | 1 |
El Rafidi, A | 1 |
Ghamarnejad, O | 1 |
Shafiei, S | 1 |
Ali-Hasan-Al-Saegh, S | 1 |
Probst, P | 1 |
Hoffmann, K | 1 |
Mehrabi, A | 1 |
Ferrer Inaebnit, E | 1 |
Molina Romero, FX | 1 |
Segura Sampedro, JJ | 1 |
González Argenté, X | 1 |
Morón Canis, JM | 1 |
Petrone, L | 1 |
Tamarozzi, F | 3 |
Vola, A | 2 |
Gomez Morales, MA | 1 |
Ludovisi, A | 1 |
Najafi Fard, S | 1 |
Mariconti, M | 1 |
Goletti, D | 1 |
Cangalaya, C | 1 |
Bustos, JA | 1 |
Calcina, J | 1 |
Vargas-Calla, A | 1 |
Mamani, J | 1 |
Suarez, D | 1 |
Arroyo, G | 1 |
Gonzalez, AE | 1 |
Chacaltana, J | 1 |
Guerra-Giraldez, C | 1 |
Mahanty, S | 1 |
Nash, TE | 1 |
García, HH | 3 |
Del Brutto, OH | 1 |
Firpo, G | 1 |
Lissandrin, R | 2 |
Keong, B | 1 |
Wilkie, B | 1 |
Sutherland, T | 1 |
Fox, A | 1 |
Mughal, A | 2 |
Minhas, MS | 1 |
Bhatti, A | 1 |
Moghul, FA | 1 |
Sangani, MM | 1 |
Khan, KM | 1 |
Alam, A | 1 |
Kumar, M | 1 |
Velasco-Tirado, V | 1 |
Romero-Alegria, A | 1 |
Pardo-Lledías, J | 1 |
Alonso-Sardón, M | 1 |
Lopez-Bernus, A | 1 |
Sampedro, JQ | 1 |
Bellvis, LM | 1 |
Iglesias Gomez, A | 1 |
Muro, A | 1 |
Muñoz Bellido, JL | 1 |
Iglesias-Iglesias, M | 1 |
Jimenez Lopez, MF | 1 |
Belhassen-García, M | 1 |
Maggiore, MA | 1 |
Pensel, PE | 1 |
Albani, CM | 1 |
Denegri, GM | 1 |
Tersigni, C | 1 |
Semeraro, A | 1 |
Caremani, M | 1 |
Venturini, E | 1 |
Defilippi, C | 1 |
de Martino, M | 1 |
Galli, L | 1 |
Legonkov, YA | 1 |
Bronshtein, AM | 1 |
Moscatelli, G | 1 |
Moroni, S | 1 |
Freilij, H | 1 |
Salgueiro, F | 1 |
García Bournissen, F | 1 |
Altcheh, J | 1 |
Küçük, Z | 1 |
Karcaaltincaba, D | 1 |
Ergün, Y | 1 |
Doğan, AÇ | 1 |
Çaydere, M | 1 |
Küçük, H | 1 |
Rinaldi, F | 1 |
De Silvestri, A | 1 |
Cattaneo, F | 1 |
Romo, ML | 1 |
Wyka, K | 1 |
Carpio, A | 2 |
Leslie, D | 2 |
Andrews, H | 2 |
Bagiella, E | 2 |
Hauser, WA | 2 |
Kelvin, EA | 2 |
Arce, MA | 1 |
Limaylla, H | 1 |
Valcarcel, M | 1 |
Santivañez, SJ | 1 |
Tzili, N | 1 |
Ahbeddou, S | 1 |
Ahmimech, J | 1 |
Abboud, H | 1 |
Boutarbouch, M | 1 |
El Hassan, A | 1 |
Berraho, A | 1 |
Kwon, BW | 1 |
Park, SJ | 1 |
Kong, JH | 1 |
Song, IH | 1 |
Lötsch, F | 1 |
Naderer, J | 1 |
Skuhala, T | 1 |
Groger, M | 1 |
Auer, H | 1 |
Kaczirek, K | 1 |
Waneck, F | 1 |
Ramharter, M | 2 |
Capan, M | 1 |
Keltner, S | 1 |
Thalhammer, F | 1 |
Winkler, S | 1 |
Jäger, W | 1 |
Zeitlinger, M | 1 |
Riganò, R | 1 |
Ioppolo, S | 1 |
Ortona, E | 1 |
Margutti, P | 1 |
Profumo, E | 1 |
Ali, MD | 1 |
Di Vico, B | 1 |
Teggi, A | 1 |
Siracusano, A | 1 |
Shao, Y | 1 |
Liu, W | 1 |
Wen, H | 1 |
Delobel, P | 1 |
Signate, A | 1 |
El Guedj, M | 1 |
Couppie, P | 1 |
Gueye, M | 1 |
Smadja, D | 1 |
Pradinaud, R | 1 |
Todorov, T | 1 |
Vutova, K | 1 |
Donev, S | 1 |
Ivanov, A | 1 |
Katzarov, K | 1 |
Takov, D | 1 |
Patnaik, MM | 1 |
Deshpande, AK | 1 |
Leon, P | 1 |
Sekhar, GC | 1 |
Lemke, BN | 1 |
Deger, E | 1 |
Hokelek, M | 1 |
Deger, BA | 1 |
Tutar, E | 1 |
Asil, M | 1 |
Pakdemirli, E | 1 |
Peláez, V | 1 |
Kugler, C | 1 |
Correa, D | 1 |
Del Carpio, M | 1 |
Guangiroli, M | 1 |
Molina, J | 1 |
Marcos, B | 1 |
Lopez, E | 1 |
Gulliani, BP | 1 |
Dadeya, S | 1 |
Malik, KP | 1 |
Jain, DC | 1 |
Moreno, MJ | 1 |
Casado, N | 1 |
Urrea-París, MA | 1 |
Rodríguez-Caabeiro, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Characteristics of Patients With Symptomatic Active Neurocysticercosis and Effect of Treatment on Symptoms, Lesions and Quality of Life in Resource-poor Rural Areas of Eastern Africa - TOPANA, a Multi-centre Prospective Cohort Study.[NCT03834337] | 63 participants (Actual) | Observational | 2019-04-01 | Completed | |||
A Pilot Study of Neurocysticercosis Treatment[NCT00283699] | Phase 3 | 178 participants (Actual) | Interventional | 2001-02-28 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for albendazole and Cyst
Article | Year |
---|---|
An unexpected guest: Pulmonary echinococcosis diagnosed by intraoperative frozen section examination. A case report and literature review.
Topics: Albendazole; Animals; Cysts; Echinococcosis, Pulmonary; Echinococcus granulosus; Frozen Sections; Hu | 2023 |
Pulmonary cystic echinococcosis.
Topics: Albendazole; Cysts; Echinococcosis; Echinococcosis, Hepatic; Humans; Lung | 2023 |
Endocystectomy as a conservative surgical treatment for hepatic cystic echinococcosis: A systematic review with single-arm meta-analysis.
Topics: Albendazole; Animals; Anticestodal Agents; Cysts; Echinococcosis; Echinococcosis, Hepatic; Echinococ | 2021 |
A review of the diagnosis and management of liver hydatid cyst.
Topics: Albendazole; Cysts; Echinococcosis; Echinococcosis, Hepatic; Humans; Liver Diseases | 2022 |
Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
Topics: Albendazole; Anticestodal Agents; Antiparasitic Agents; Brain; Cysts; Epilepsy; Female; Humans; Infl | 2017 |
Hepatic cystic echinococcosis in Australia: an update on diagnosis and management.
Topics: Adult; Albendazole; Animals; Anthelmintics; Australia; Conservative Treatment; Cysts; Echinococcosis | 2018 |
Primary Giant Splenic Echinococcal Cyst Treated by Laparoscopy.
Topics: Aged; Albendazole; Anthelmintics; Cysts; Echinococcosis; Female; Humans; Splenic Diseases | 2016 |
Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
Topics: Albendazole; Animals; Anthelmintics; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Praziqu | 2016 |
5 trials available for albendazole and Cyst
Article | Year |
---|---|
The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.
Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Brain; Cysts; Drug Therapy, Combinati | 2015 |
Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates.
Topics: Adult; Aged; Albendazole; Animals; Antibodies, Helminth; Anticestodal Agents; Biomarkers; Cysts; Dis | 2002 |
The types and timing of the degenerative changes seen in the cysts during and after benzimidazole treatment of cystic echinococcosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anticestodal Agents; Benzimidazoles; Child; Cys | 2005 |
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Anti-Inflammatory Agents; Antiparasitic Agents; Brain; | 2008 |
PAIR as percutaneous treatment of hydatid liver cysts.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Anthelmintics; Argentina; Cysts; Drainage; | 2000 |
36 other studies available for albendazole and Cyst
Article | Year |
---|---|
Rare Encounter of Renal Hydatid Cyst: A Case Report.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Female; Humans; Kidney Neoplas | 2021 |
In vitro evaluation of albendazole-loaded nanostructured lipid carriers on Echinococcus granulosus microcysts and their prophylactic efficacy on experimental secondary hydatidosis.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Lipids; Mice | 2021 |
Hydatid Disease in Children from Diagnosis to Treatment: A 10-year Single Center Experience
Topics: Albendazole; Animals; Child; Cysts; Echinococcosis; Echinococcus granulosus; Female; Humans; Male; R | 2022 |
Efficacy and safety of praziquantel in the treatment of neurocysticercosis in Vietnam.
Topics: Alanine Transaminase; Albendazole; Anthelmintics; Anticonvulsants; Antiparasitic Agents; Aspartate A | 2022 |
Anti-echinococcal effects of sumac, Rhus coriaria, in a murine model of cystic echinococcosis: Parasitological and molecular evaluation.
Topics: Albendazole; Animals; Cysts; Disease Models, Animal; Echinococcosis; Echinococcus; Echinococcus gran | 2022 |
Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Mice; Thymol | 2023 |
Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Mice; Thymol | 2023 |
Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Mice; Thymol | 2023 |
Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Mice; Thymol | 2023 |
Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Mice; Thymol | 2023 |
Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Mice; Thymol | 2023 |
Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Mice; Thymol | 2023 |
Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Mice; Thymol | 2023 |
Experimental treatment of cystic echinococcosis: Combination therapy with carvacrol and thymol versus albendazole.
Topics: Albendazole; Animals; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Mice; Thymol | 2023 |
[A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye].
Topics: Albendazole; Animals; Brain; Cysticercosis; Cysts; Humans; Neurocysticercosis; Swine | 2022 |
[A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye].
Topics: Albendazole; Animals; Brain; Cysticercosis; Cysts; Humans; Neurocysticercosis; Swine | 2022 |
[A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye].
Topics: Albendazole; Animals; Brain; Cysticercosis; Cysts; Humans; Neurocysticercosis; Swine | 2022 |
[A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye].
Topics: Albendazole; Animals; Brain; Cysticercosis; Cysts; Humans; Neurocysticercosis; Swine | 2022 |
Atypical presentations of hydatid cyst in children and their management.
Topics: Albendazole; Child; Cysts; Echinococcosis; Echinococcosis, Hepatic; Female; Humans; Male | 2022 |
Atypical presentations of hydatid cyst in children and their management.
Topics: Albendazole; Child; Cysts; Echinococcosis; Echinococcosis, Hepatic; Female; Humans; Male | 2022 |
Atypical presentations of hydatid cyst in children and their management.
Topics: Albendazole; Child; Cysts; Echinococcosis; Echinococcosis, Hepatic; Female; Humans; Male | 2022 |
Atypical presentations of hydatid cyst in children and their management.
Topics: Albendazole; Child; Cysts; Echinococcosis; Echinococcosis, Hepatic; Female; Humans; Male | 2022 |
Treatment of Cystic Echinococcosis in Children: A Single Center Experience.
Topics: Albendazole; Anthelmintics; Child; Cysts; Echinococcosis; Humans; Retrospective Studies | 2023 |
Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study.
Topics: Albendazole; Anthelmintics; Antiparasitic Agents; Cysts; Humans; Neurocysticercosis; Praziquantel; P | 2023 |
Renal Hydatid Cyst in a Child Managed with Albendazole.
Topics: Adolescent; Albendazole; Child; Cysts; Echinococcosis; Female; Humans; Kidney; Kidney Neoplasms; Nep | 2023 |
Central Pericystectomy for Hydatid Cyst Treatment.
Topics: Adult; Albendazole; Cysts; Echinococcosis, Hepatic; Hepatic Veins; Humans; Laparoscopy; Male; Vena C | 2023 |
Pulmonary cystic echinococcosis in a child.
Topics: Adolescent; Albendazole; Animals; Child; Cysts; Echinococcosis; Echinococcosis, Pulmonary; Echinococ | 2023 |
Albendazole Monotherapy for Pediatric Cystic Echinococcosis: A Case Series.
Topics: Albendazole; Child; Cysts; Echinococcosis; Echinococcosis, Hepatic; Humans; Retrospective Studies | 2023 |
The high burden of pediatric cystic echinococcosis in Kazakhstan: epidemiological and clinical consequences.
Topics: Albendazole; Animals; Child; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Kazakhstan | 2023 |
Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts.
Topics: Adult; Aged; Albendazole; Animals; Cysts; Cytokines; Echinococcosis; Echinococcus granulosus; Female | 2021 |
Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.
Topics: Albendazole; Animals; Anthelmintics; Brain; Cysts; Disease Models, Animal; Drug Therapy, Combination | 2017 |
Preliminary Evaluation of Percutaneous Treatment of Echinococcal Cysts without Injection of Scolicidal Agent.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelm | 2017 |
Hydatid Cyst of Skeletal Muscle Presenting as Soft Tissue Tumour.
Topics: Albendazole; Animals; Anthelmintics; Biopsy; Cysts; Diagnosis, Differential; Echinococcosis; Echinoc | 2018 |
Management of cystic echinococcosis in the last two decades: what have we learned?
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Clinical Protocols; Combined Mo | 2018 |
Could beta-myrcene be an alternative to albendazole for the treatment of experimental cystic echinococcosis?
Topics: Acyclic Monoterpenes; Albendazole; Animals; Cells, Cultured; Cysts; Echinococcosis; Echinococcus gra | 2018 |
Case Report: Percutaneous Treatment of Multiple Echinococcal Cysts Presenting as Abdominal Palpable Mass.
Topics: Abdomen; Abdominal Pain; Administration, Cutaneous; Adolescent; Albendazole; Animals; Anticestodal A | 2019 |
[(EXPERIENCE WITH ALBENDAZOLE TREATMENT IN CHILDREN WITH CYSTIC ECHINOCOCCOSIS)].
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Cysts; Echinococcosis; Ech | 2017 |
A five-year-old child with renal hydatidosis.
Topics: Albendazole; Animals; Argentina; Child, Preschool; Cysts; Echinococcosis; Echinococcus granulosus; E | 2013 |
Isolated hydatid cyst of uterine cervix: A case report.
Topics: Adult; Albendazole; Anthelmintics; Cervix Uteri; Combined Modality Therapy; Cysts; Diagnosis, Differ | 2014 |
Medical treatment versus "Watch and Wait" in the clinical management of CE3b echinococcal cysts of the liver.
Topics: Adolescent; Adult; Aged; Albendazole; Child; Cysts; Echinococcosis, Hepatic; Female; Humans; Male; M | 2014 |
Swollen eyelid reveals multiple intracranial hydatid cysts associated with a palpebral cyst.
Topics: Albendazole; Brain Diseases; Central Nervous System Helminthiasis; Child; Cysts; Echinococcosis; Ede | 2016 |
Daughter cysts in a cyst of the liver: hepatic echinococcosis.
Topics: Albendazole; Anthelmintics; Biopsy; Combined Modality Therapy; Cysts; Echinococcosis, Hepatic; Hepat | 2016 |
Intra-cystic drug concentration of albendazole sulphoxide in patients with Echinococcus granulosus cysts.
Topics: Adult; Albendazole; Animals; Anticestodal Agents; Cysts; Echinococcosis, Hepatic; Echinococcus granu | 2009 |
[Effect of liposomal albendazole on the ultrastructure of Echinococcus granulosus cysts in mice].
Topics: Albendazole; Animals; Anticestodal Agents; Cysts; Disease Models, Animal; Drug Delivery Systems; Ech | 1999 |
Unusual form of neurocysticercosis associated with HIV infection.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Brain; Cysts; Epidural S | 2004 |
Diagnosis--hydatid cyst disease.
Topics: Albendazole; Animals; Antiprotozoal Agents; Cysts; Echinococcosis; Echinococcus; Humans; India; Live | 2007 |
Orbital cysticercosis.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Conjunctiva; Conjun | 1997 |
A new therapeutic approach for the treatment of cystic echinococcosis: percutaneous albendazole sulphoxide injection without reaspiration.
Topics: Albendazole; Animals; Anticestodal Agents; Cysts; Echinococcosis, Hepatic; Injections, Intralesional | 2000 |
Bilateral cysticercosis of the optic nerve.
Topics: Adult; Albendazole; Antiprotozoal Agents; Cysts; Eye Infections, Parasitic; Humans; Magnetic Resonan | 2001 |
Could ivermectin have a synergic effect with albendazole in hydatidosis therapy?
Topics: Albendazole; Animals; Anticestodal Agents; Cysts; Drug Synergism; Drug Therapy, Combination; Echinoc | 2002 |